As of 2025-09-17, the Relative Valuation of Eupraxia Pharmaceuticals Inc (EPRX.TO) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 7.26 CAD, the upside of Eupraxia Pharmaceuticals Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-08-22 | -10.05 |
| 2025-08-21 | -9.87 |
| 2025-08-20 | -10.07 |
| 2025-08-19 | -10.22 |
| 2025-08-18 | -10.12 |
| 2025-08-15 | -10.11 |
| 2025-08-14 | -9.93 |
| 2025-08-13 | -10.27 |
| 2025-08-12 | -10.22 |
| 2025-08-11 | -10.05 |
| 2025-08-08 | -9.89 |
| 2025-08-07 | -10.15 |
| 2025-08-06 | -10.39 |
| 2025-08-05 | -10.15 |
| 2025-08-01 | -10.04 |
| 2025-07-31 | -10.23 |
| 2025-07-30 | -9.89 |
| 2025-07-29 | -10.49 |
| 2025-07-28 | -10.67 |
| 2025-07-25 | -10.35 |
| 2025-07-24 | -10.35 |
| 2025-07-23 | -9.61 |
| 2025-07-22 | -9.42 |
| 2025-07-21 | -9.61 |
| 2025-07-18 | -9.87 |
| 2025-07-17 | -10.19 |
| 2025-07-16 | -10.19 |
| 2025-07-15 | -10.05 |
| 2025-07-14 | -10.33 |
| 2025-07-11 | -10.46 |
| 2025-07-10 | -10.46 |
| 2025-07-09 | -10.19 |
| 2025-07-08 | -10.56 |
| 2025-07-07 | -10.42 |
| 2025-07-04 | -10.49 |
| 2025-07-03 | -10.13 |
| 2025-07-02 | -10.19 |
| 2025-06-30 | -10.75 |
| 2025-06-27 | -10.08 |
| 2025-06-26 | -8.75 |
| 2025-06-25 | -8.26 |
| 2025-06-24 | -8.19 |
| 2025-06-23 | -8.12 |
| 2025-06-20 | -8.27 |
| 2025-06-19 | -8.30 |
| 2025-06-18 | -8.01 |
| 2025-06-17 | -8.12 |
| 2025-06-16 | -7.82 |
| 2025-06-13 | -7.34 |
| 2025-06-12 | -7.32 |